177 related articles for article (PubMed ID: 26799199)
21. Association between NFKB1 -94ins/delATTG promoter polymorphism and cancer risk: a meta-analysis.
Zou YF; Yuan FL; Feng XL; Tao JH; Ding N; Pan FM; Wang F
Cancer Invest; 2011 Jan; 29(1):78-85. PubMed ID: 21166501
[TBL] [Abstract][Full Text] [Related]
22. A functional promoter polymorphism in NFKB1 increases susceptibility to endometriosis.
Zhou B; Rao L; Peng Y; Wang Y; Qie M; Zhang Z; Song Y; Zhang L
DNA Cell Biol; 2010 May; 29(5):235-9. PubMed ID: 20218898
[TBL] [Abstract][Full Text] [Related]
23. Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population.
Koc A; Batar B; Celik O; Onaran I; Tasan E; Sultuybek GK
Immunobiology; 2014 Jul; 219(7):531-6. PubMed ID: 24703107
[TBL] [Abstract][Full Text] [Related]
24. NFKB1 gene rs28362491 ins/del variation is associated with higher susceptibility to myocardial infarction in a Chinese Han population.
Luo JY; Li YH; Fang BB; Tian T; Liu F; Li XM; Gao XM; Yang YN
Sci Rep; 2020 Nov; 10(1):19518. PubMed ID: 33177541
[TBL] [Abstract][Full Text] [Related]
25. Association between genetic polymorphism in NFKB1 and NFKBIA and coronary artery disease in a Chinese Han population.
Lai H; Chen Q; Li X; Ma Y; Xu R; Zhai H; Liu F; Chen B; Yang Y
Int J Clin Exp Med; 2015; 8(11):21487-96. PubMed ID: 26885097
[TBL] [Abstract][Full Text] [Related]
26. Meta-analysis of NFKB1-94 ATTG Ins/Del Polymorphism and Risk of Breast Cancer.
Kancharla J; Prasad IDV; Bhaskar LVKS; Bramhachari PV; Alam A
Curr Drug Metab; 2020; 21(3):221-225. PubMed ID: 32156231
[TBL] [Abstract][Full Text] [Related]
27. The association between NFKB1-94ins/del ATTG polymorphism and non-small cell lung cancer risk in a Chinese Han population.
Wang Y; Chen L; Pan L; Xue J; Yu H
Int J Clin Exp Med; 2015; 8(5):8153-7. PubMed ID: 26221384
[TBL] [Abstract][Full Text] [Related]
28. The NFKB1 ATTG ins/del polymorphism and risk of coronary heart disease in three independent populations.
Vogel U; Jensen MK; Due KM; Rimm EB; Wallin H; Nielsen MR; Pedersen AP; Tjønneland A; Overvad K
Atherosclerosis; 2011 Nov; 219(1):200-4. PubMed ID: 21726863
[TBL] [Abstract][Full Text] [Related]
29. Updated meta-analysis of NFkappaB1 -94ins/Delattg promoter polymorphism and cancer risk based on 19 case-control studies.
Wang X; Lu P; Xu L; Xu Y; Shi Z; Xu J; Wang Y; Zhang J; Wang X; Cao L; Liu N; Yin Y; You Y
Asian Pac J Cancer Prev; 2011; 12(10):2479-84. PubMed ID: 22320942
[TBL] [Abstract][Full Text] [Related]
30. Relationship between the
Chen J; Ge D; Xiong Y
Clin Exp Hypertens; 2019; 41(6):577-582. PubMed ID: 30285510
[No Abstract] [Full Text] [Related]
31. Genetic association between NFKB1 -94 ins/del ATTG Promoter Polymorphism and cancer risk: a meta-analysis of 42 case-control studies.
Wang D; Xie T; Xu J; Wang H; Zeng W; Rao S; Zhou K; Pei F; Zhou Z
Sci Rep; 2016 Jul; 6():30220. PubMed ID: 27443693
[TBL] [Abstract][Full Text] [Related]
32. NFKB1 -94 insertion/deletion ATTG polymorphism contributes to risk of systemic lupus erythematosus.
Gao M; Wang CH; Sima X; Han XM
DNA Cell Biol; 2012 Apr; 31(4):611-5. PubMed ID: 22013908
[TBL] [Abstract][Full Text] [Related]
33. Roles of functional NFKB1 and β-TrCP insertion/deletion polymorphisms in mRNA expression and epithelial ovarian cancer susceptibility.
Huo ZH; Zhong HJ; Zhu YS; Xing B; Tang H
Genet Mol Res; 2013 Mar; 12(3):3435-43. PubMed ID: 23546975
[TBL] [Abstract][Full Text] [Related]
34. NFKB1 gene rs28362491 polymorphism is associated with the susceptibility of acute coronary syndrome.
Jin SY; Luo JY; Li XM; Liu F; Ma YT; Gao XM; Yang YN
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910844
[TBL] [Abstract][Full Text] [Related]
35. Relationship between NFKB1 -94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk.
Zhou B; Qie M; Wang Y; Yan L; Zhang Z; Liang A; Wang T; Wang X; Song Y; Zhang L
Ann Oncol; 2010 Mar; 21(3):506-511. PubMed ID: 19892748
[TBL] [Abstract][Full Text] [Related]
36. A functional insertion/deletion polymorphism in the promoter region of the NFKB1 gene increases the risk of papillary thyroid carcinoma.
Wang X; Peng H; Liang Y; Sun R; Wei T; Li Z; Gong Y; Gong R; Liu F; Zhang L; Zhu J
Genet Test Mol Biomarkers; 2015 Mar; 19(3):167-71. PubMed ID: 25692306
[TBL] [Abstract][Full Text] [Related]
37. Contributions of NFKB1 -94insertion/deletion ATTG polymorphism to the susceptibility of gastrointestinal cancers: A meta-analysis.
Wu H; Liang J
J Cell Mol Med; 2021 Nov; 25(22):10674-10683. PubMed ID: 34672421
[TBL] [Abstract][Full Text] [Related]
38. NFKB1 -94ins/del ATTG polymorphism increases osteosarcoma risk in a Chinese Han population.
Li X; Zhang C; Qiao W; Zhou X; Sun M
Int J Clin Exp Med; 2015; 8(1):1420-3. PubMed ID: 25785149
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms in CYP19A1 and NFKB1 genes are associated with cutaneous melanoma risk in southern Brazilian patients.
Escobar GF; Arraes JA; Bakos L; Ashton-Prolla P; Giugliani R; Callegari-Jacques SM; Santos S; Bakos RM
Melanoma Res; 2016 Aug; 26(4):348-53. PubMed ID: 27145040
[TBL] [Abstract][Full Text] [Related]
40. Insertion/deletion polymorphism in the promoter of NFKB1 influences severity but not mortality of acute respiratory distress syndrome.
Adamzik M; Frey UH; Rieman K; Sixt S; Beiderlinden M; Siffert W; Peters J
Intensive Care Med; 2007 Jul; 33(7):1199-1203. PubMed ID: 17468848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
